Journal article icon

Journal article

Genetic testing in motor neurone disease

Abstract:
Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease that results from the loss of upper and lower motor neurons. Despite a heterogeneous, complex genetic background, one aspect that connects 97% of ALS patients is the presence of abnormal protein aggregates in motor neurons with TDP-43 as the main constituent. Moreover, mutations in the TARDBP gene are also known to be causative in 4% of familial cases and 1% of sporadic ALS patients. This indicates that TDP-43 is central to ALS pathogenesis. To investigate this key aspect of ALS, we used the Thy1-hTDP-43 mouse model, a severe model of ALS with a lifespan of 20-25 postnatal days (P). Here, we have quantified TDP-43 protein expression over the mouse lifespan, facilitating comparison with other disease phenotypes; such as motor neuron cell death and NMJ denervation. Using human-specific versus pan-mammalian antibodies for TDP-43, we compared the expression of pathological hTDP-43 and endogenous mouse TDP-43 in the spinal cord and brain, via western blotting. To document cell death, blinded motor neuron counts were performed at pre-symptomatic (P8), early-symptomatic (P15) and symptomatic (P17) timepoints, as well as at disease end-stage (P19-21). Our results demonstrate a significant overexpression of pathological hTDP-43 pre-symptomatically, leading to an 8-fold increase in TDP-43 expression at end-stage in homozygous Tg/Tg mice. Interestingly, non-symptomatic heterozygous littermates also showed overexpression of hTDP-43 up to P15, where expression then plateaued at a two-fold increase compared to wild-types for up to 9 months. Motor neuron counts showed that there was a significant overall loss of motor neurons from the ventral horn in hTDP-43 Tg/Tg mice at end-stage (n=3 mice per genotype, N=18 spinal cord slices analysed per genotype, P-value=0.02). This detailed analysis of the time course of TDP-43 overexpression and motor neuron loss will allow us to investigate the order of pathological events in the Thy1-hTDP-43 model, including the timing of neuromuscular junction denervation compared to motor neuron cell death
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1136/practneurol-2021-002989
Publication website:
https://era.ed.ac.uk/bitstream/1842/42328/1/ShandMS_2024.pdf

Authors

More by this author
Institution:
University of Oxford
Role:
Author
More by this author
Institution:
University of Oxford
Role:
Author
More by this author
Institution:
University of Oxford
Role:
Author
More by this author
Institution:
University of Oxford
Role:
Author
More by this author
Institution:
University of Oxford
Role:
Author


More from this funder
Funder identifier:
10.13039/501100001774
Grant:
CJ Martin Fellowship (TD)
More from this funder
Funder identifier:
10.13039/501100000406
Grant:
Clinician Scientist Fellowship (AGT)
More from this funder
Funder identifier:
10.13039/501100000925
Grant:
CJ Martin Post-Doctoral Fellowship
More from this funder
Funder identifier:
10.13039/501100000265


Publisher:
BMJ Publishing Group
Journal:
Practical Neurology More from this journal
Volume:
22
Issue:
2
Pages:
107-116
Publication date:
2022-01-13
Acceptance date:
2021-12-05
DOI:
EISSN:
1474-7766
ISSN:
1474-7758


Language:
English
Keywords:
Pubs id:
1232636
Local pid:
pubs:1232636
Source identifiers:
W4206395867
Deposit date:
2026-04-09
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP